217 related articles for article (PubMed ID: 20515022)
1. Unusual dimeric chemical structure for a carboplatin analogue as a potential anticancer complex.
Xie M; Liu W; Lou L; Chen X; Ye Q; Yu Y; Chang Q; Hou S
Inorg Chem; 2010 Jul; 49(13):5792-4. PubMed ID: 20515022
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro cytotoxicity of cis-[Pt(NH(3))(NH(2)OH)Cl(2)].
Ye QS; Liu WP; Chen XZ; Yu Y; Chang QW; Hou SQ
Arch Pharm Res; 2010 Jun; 33(6):807-11. PubMed ID: 20607484
[TBL] [Abstract][Full Text] [Related]
4. A platinum Chugaev carbene complex as a potent anticancer agent.
Alves G; Morel L; El-Ghozzi M; Avignant D; Legeret B; Nauton L; Cisnetti F; Gautier A
Chem Commun (Camb); 2011 Jul; 47(27):7830-2. PubMed ID: 21647511
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxicity of platinum(II) complexes of a physiologically active carrier histamine.
Chen XZ; Ye QS; Lou LG; Xie MJ; Liu WP; Yu Y; Hou SQ
Arch Pharm (Weinheim); 2008 Feb; 341(2):132-6. PubMed ID: 18186542
[TBL] [Abstract][Full Text] [Related]
6. A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.
Liu W; Chen X; Ye Q; Xu Y; Xie C; Xie M; Chang Q; Lou L
Inorg Chem; 2011 Jun; 50(12):5324-6. PubMed ID: 21598993
[TBL] [Abstract][Full Text] [Related]
7. Chemical, structural and biological studies of cis-[Pt(3-Acpy)(2)Cl(2)].
Tian T; Mutikainen I; van Wezel GP; Aliaga-Alcalde N; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1221-7. PubMed ID: 19635634
[TBL] [Abstract][Full Text] [Related]
8. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
[TBL] [Abstract][Full Text] [Related]
9. Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand.
Zhao J; Gou S; Liu F
Chemistry; 2014 Nov; 20(46):15216-25. PubMed ID: 25256173
[TBL] [Abstract][Full Text] [Related]
10. A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues.
Margiotta N; Capitelli F; Ostuni R; Natile G
J Inorg Biochem; 2008 Dec; 102(12):2078-86. PubMed ID: 18760482
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, physicochemical and in vitro pharmacological investigation of new platinum (II) complexes with some cycloalkanespiro-5'-hydantoins.
Bakalova A; Buyukliev R; Momekov G; Ivanov D; Todorov D; Konstantinov S; Karaivanova M
Eur J Med Chem; 2005 Jun; 40(6):590-6. PubMed ID: 15922842
[TBL] [Abstract][Full Text] [Related]
12. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of Pt(II) amine phosphonate complexes on sarcoma sa-180 in mice. Crystal structure of cis-dichlorobis(diethyl-4-pyridylmethylphosphonate-kappaN)platinum(II) hydrate, cis-[PtCl2(4-pmpe)2].H20.
Aranowska K; Graczyk J; Checińska L; Pakulska W; Ochock J
Pharmazie; 2006 May; 61(5):457-60. PubMed ID: 16724546
[TBL] [Abstract][Full Text] [Related]
15. Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity.
Starha P; Trávnícek Z; Popa I
J Inorg Biochem; 2010 Jun; 104(6):639-47. PubMed ID: 20304500
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
Monti E; Gariboldi M; Maiocchi A; Marengo E; Cassino C; Gabano E; Osella D
J Med Chem; 2005 Feb; 48(3):857-66. PubMed ID: 15689170
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis and antitumor activities of triazacyclodecane and its platinum (II) complex].
Zhou SS; Zhang QY; Qin K; Lu CH; Xie FX
Yao Xue Xue Bao; 2008 May; 43(5):490-4. PubMed ID: 18717336
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cytotoxic effect, and structure-activity relationship of Pd(II) complexes with coumarin derivatives.
Budzisz E; Małecka M; Lorenz IP; Mayer P; Kwiecień RA; Paneth P; Krajewska U; Rózalski M
Inorg Chem; 2006 Nov; 45(24):9688-95. PubMed ID: 17112264
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin.
Horvath G; Premkumar T; Boztas A; Lee E; Jon S; Geckeler KE
Mol Pharm; 2008; 5(2):358-63. PubMed ID: 18281942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
